![Steven Chartier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Chartier
Vorstandsvorsitzender bei
BioVentrix, Inc.
Vermögen: 1 $ am 31.01.2026
Profil
Steven J.
Chartier is Co-President, Co-CEO, and Director at BioVentrix, Inc. since 2025.
Mr. Chartier is a Member of the Regulatory Affairs Professionals Society.
Former roles include Chief Operating Officer at BioVentrix, Inc. from 2021 to 2023; Vice President-Regulatory & Clinical Affairs at Anika Therapeutics, Inc. from 2017 to 2018; Chief Operating Officer at PixarBio Corp.
from 2016 to 2017; Director-Regulatory Affairs at NUCRYST Pharmaceuticals Corp.
from 2009 to 2013; Vice President-Operations & Regulatory Affairs at Infraredx, Inc. in 2013; Manager-Clinical Projects at Biogen, Inc.; VP-Regulatory Affairs & Regulatory Affairs at Augmenix, Inc.; Principal at Dana-Farber Cancer Institute, Inc.; and Coordinator-Clinical Trials at Beth Israel Deaconess Medical Center, Inc. Education includes undergraduate studies at St. Anselm College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BioVentrix, Inc.
 BioVentrix, Inc. Medical SpecialtiesHealth Technology Develops and medical devices for the treatment of heart failures 1,93 % | 12.02.2026 | 110.530 ( 1,93 % ) | 1 $ | 31.01.2026 |
Aktive Positionen von Steven Chartier
| Unternehmen | Position | Beginn |
|---|---|---|
Regulatory Affairs Professionals Society
 Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Operates as NPO that offers healthcare products | Corporate Officer/Principal | - |
BioVentrix, Inc.
BioVentrix, Inc. Medical SpecialtiesHealth Technology Develops and medical devices for the treatment of heart failures | Vorstandsvorsitzender | 15.01.2025 |
Ehemalige bekannte Positionen von Steven Chartier
| Unternehmen | Position | Ende |
|---|---|---|
BioVentrix, Inc.
BioVentrix, Inc. Medical SpecialtiesHealth Technology Develops and medical devices for the treatment of heart failures | Geschäftsführer | 01.12.2023 |
| ANIKA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 |
| PIXARBIO CORPORATION | Geschäftsführer | 02.02.2017 |
Augmenix, Inc.
 Augmenix, Inc. Medical SpecialtiesHealth Technology Develops hydrogel technology to improve outcomes in radiation oncology and surgery | General Counsel | - |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Corporate Officer/Principal | - |
Ausbildung von Steven Chartier
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Anika Therapeutics, Inc.
 Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
BioVentrix, Inc.
BioVentrix, Inc. Medical SpecialtiesHealth Technology Develops and medical devices for the treatment of heart failures | Health Technology |
Infraredx, Inc.
 Infraredx, Inc. Medical SpecialtiesHealth Technology Develops cardiovascular imaging devices | Health Technology |
NUCRYST Pharmaceuticals Corp.
 NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes medical products that fight infection and inflammation | Health Technology |
Regulatory Affairs Professionals Society
Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Operates as NPO that offers healthcare products | Commercial Services |
Augmenix, Inc.
Augmenix, Inc. Medical SpecialtiesHealth Technology Develops hydrogel technology to improve outcomes in radiation oncology and surgery | Health Technology |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
St. Anselm College
 St. Anselm College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
PixarBio Corp.
 PixarBio Corp. Other Consumer ServicesConsumer Services Develops pre-clinical and commercial novel neurological drug delivery systems | Consumer Services |
